ACHE and Alzheimer disease: Cannabinoids are involved in the reduction of oxidative stress and of the tumor necrosis factor-α (TNF-α); they may have synergistic effect on acetylcholinesterase (AchE) inhibitors, preventing Aβ formation, and they may improve circadian rhythm disturbances commonly seen in AD [79,83].